Combined pre‐S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case‐control study in China (Q82044308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Combined pre‐S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case‐control study in China (English)

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

9 August 2024

main subject

hepatocellular carcinoma

1 reference

Li-Shuai Qu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Tao-Tao Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Fei Jin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yan-Mei Guo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Tao-Yang Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Zheng-Pin Ni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Xi-Zhong Shen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20973883

9 August 2024

publication date

25 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 January 2020

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2010.00732.x

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1872-034X.2010.00732.x

9 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

9 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

54-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus infection

14 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

9 August 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

9 August 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

9 August 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

9 August 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

9 August 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America

9 August 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Geographical and genetic diversity of the human hepatitis B virus

9 August 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

9 August 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

9 August 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

9 August 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

9 August 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.

9 August 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma

9 August 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

9 August 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection

9 August 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.

9 August 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China

9 August 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

9 August 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China

9 August 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Clinical relevance of hepatitis B viral mutations

9 August 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection

9 August 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.

9 August 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Hepatitis B virus immunopathogenesis

9 August 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen

9 August 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

9 August 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection

9 August 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Mutations on free and integrated hepatitis B virus DNA in a hepatocellular carcinoma: footprints of homologous recombination

9 August 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study

9 August 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection

9 August 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation

9 August 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

9 August 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study

9 August 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China

9 August 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00732.X

9 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20973883%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference